Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia [Phase 3]
Phase 3 study evaluating the efficacy and safety of topiramate in obese adults with dyslipidemia. The trial was terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Differential Metabolic Effects of Fenofibrate and Fatty Acid [Phase 4]
Phase 4 trial evaluating differential metabolic effects of fenofibrate versus a fatty acid supplement in individuals with hypertriglyceridem…
-
FDA approval · 2011-05-08FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate (generic) from Rhodes Pharmaceuticals L.P., granting approval for an ANDA-relate…
-
FDA approval · 2011-03-14FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients [NA]
A completed clinical trial evaluated the use of niacin to treat elevated cholesterol and triglycerides in HIV-infected patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-02-16FDA Approved: GEMFIBROZIL — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for gemfibrozil submitted by Northstar RxLLC under an ANDA.
-
CLINICAL_TRIALS research · 2011-01-17Clinical Trial Update: Therapeutic Lifestyle Modifications to Reduce Burden of Chronic Disease [NA]
This document reports the completion of a clinical trial evaluating therapeutic lifestyle modifications to reduce the burden of chronic dise…
-
FDA approval · 2010-12-22FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC for the treatment of hyp…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients [NA]
A completed clinical trial evaluated pioglitazone for attenuating metabolic dysmetabolism in peritoneal dialysis patients, including effects…
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Diazoxide Choline in Hypertriglyceridemia [Phase 2]
A Phase 2 clinical trial evaluating diazoxide choline for hypertriglyceridemia has completed.
-
CLINICAL_TRIALS research · 2010-11-08Clinical Trial Update: Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations [Phase 1]
Open-label Phase 1 pharmacokinetic study comparing diazoxide choline coated versus uncoated formulations for hypertriglyceridemia; trial sta…
-
FDA approval · 2010-09-14FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC. Fenofibric acid is a lipid-lowe…
-
FDA approval · 2010-09-13FDA Approved: GEMFIBROZIL — Original Application (Northstar RxLLC)
FDA approved the original ANDA for gemfibrozil from Northstar RxLLC, providing a generic version of the lipid-lowering drug.
-
CLINICAL_TRIALS trial_result · 2010-07-15Clinical Trial Update: Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients [Phase 3]
This Phase 3 clinical trial reports on the effect of telmisartan on inflammatory parameters in hypertensive patients, including those with m…
-
CLINICAL_TRIALS trial_result · 2010-06-08Clinical Trial Update: Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients [Phase 4]
Phase 4 clinical trial evaluating rosuvastatin's effect on triglyceride levels in Mexican patients with hypertriglyceridemia; results have b…
-
FDA approval · 2010-04-30FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing changes to the approved product under …
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Effects of Monascus Garlic Fermented Extract on Serum Triglyceride Level [NA]
A clinical trial evaluating Monascus garlic fermented extract for reducing serum triglycerides in hypertriglyceridemia has completed.
-
CLINICAL_TRIALS research · 2010-03-12Clinical Trial Update: Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
This clinical trial update examines the effects of omega-3 fatty acids on platelet function in patients with coronary artery disease and hyp…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals. [NA]
A completed clinical trial evaluated the impact of soluble fiber on triglyceride levels and immune profile in HIV-positive individuals.
-
FDA approval · 2010-01-04FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P. under the ANDA process.
-
CLINICAL_TRIALS trial_result · 2009-12-14Clinical Trial Update: Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension [Phase 4]
Phase 4 study assessing the efficacy and safety of adding Omacor (omega-3-acid ethyl esters) to fenofibrate in hypertriglyceridemic patients…
-
FDA label_change · 2009-09-16FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC, resulting in labeli…
-
CLINICAL_TRIALS research · 2009-08-06Clinical Trial Update: The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial update evaluating OMACOR (omega-3 fatty acid) on LDL sub-fractions in adults with type 2 diabetes and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects [Phase 3]
Open-label extension of a Phase 3 randomized trial evaluating Lovaza (omega-3-acid ethyl esters) in combination with simvastatin for hypertr…
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™ [Phase 4]
This clinical trial update reports results from a second open-label extension of a Phase IV study evaluating adjunctive Lovaza (omega-3-acid…